204 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
Intoxication patients presenting to the emergency department combined with a larger THC challenge study in volunteers could potentially provide substantial
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
Intoxication patients presenting to the emergency department combined with a larger THC challenge study in volunteers could potentially provide substantial
8-K
EX-10.1
ftr83jkp950
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
S-3ASR
EX-1.2
5wttgpcw7o1r1pef
30 Sep 22
Automatic shelf registration
4:17pm
425
pvtlohfr0rjp5 kgay
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
7fk1 ek08zq55e
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
6jnaoux86xkp qu6ib
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-99.1
s62oj7iwy ucu
9 Nov 21
Ligand Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
djpv36xtbz7c epta
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K/A
EX-99.1
4x74yz g1
10 Dec 20
Financial Statements and Exhibits
4:13pm